Everolimus after failure of one prior VEGF-targeted therapy in metastatic renal cell carcinoma: Final results of the MARC-2 trial.
Everolimus after failure of a prior VEGF-targeted therapy in metastatic renal cell carcinoma : final results of the MARC-2 trial